Buspirone Plus Omeprazole for Functional Dyspepsia

I

Isfahan University of Medical Sciences

Status and phase

Completed
Phase 4

Conditions

Dyspepsia

Treatments

Drug: Buspirone
Drug: Placebo Oral Tablet

Study type

Interventional

Funder types

Other

Identifiers

NCT03444831
166681

Details and patient eligibility

About

This study is a double-blinded Randomised clinical trial aim to compare buspirone plus omeprazole with placebo plus omeprazole.

Enrollment

70 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • being over 18-year-old, Rome III criteria for FD
  • normal upper endoscopy within five years
  • negative Urease test for H-pylori
  • acceptance informed concept form.

Exclusion criteria

  • denied to get these medications
  • taking other drugs for FD
  • patients with the organic gastrointestinal disorder

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

70 participants in 2 patient groups, including a placebo group

Buspirone plus Omeprazole
Experimental group
Treatment:
Drug: Buspirone
Placebo plus Omeprazole
Placebo Comparator group
Treatment:
Drug: Placebo Oral Tablet

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems